Autoimmunity · 2009 · 21 citations · 6 references
Veterinary MedicineImmunologyPharmacologyHost-pathogen InteractionsInflammationInnate ImmunityInflammation In Infectious DiseaseInflammatory ArthritisInflammatory SignalingInnate Immune Signaling PathwaysInnate Immunity To ParasitesProtozoan Host-parasite InteractionsAcute-phase MediatorsAcute-phase ProteinsAntileishmanial TreatmentImmunopathology Of LeishmaniasisLeishmaniasis PathogenesisLeishmaniasis PathologyMacrophage Responses To LeishmaniaTreatment Of Leishmaniasis
The lipoxin A4 receptor (ALX) is an important target of LxA4 in synovial tissues of patients with inflammatory arthritis. Previously this receptor was known as the FPRL-1 on PMN and shown to interact with acute phase proteins and a variety of peptides. ALX signalling can either activate or deactivate PMN functions. In this study, we found that both LxA4 and a chemotactic lipid leishmania chemotactic factor released by the parasite leishmania increased infectivity of this pathogen in an ALX dependent fashion. This functional characterization of ALX could lead to development of novel, therapeutic targets for treatment inflammatory diseases.
6
Raffaele Badolato, J M Wang, William J. Murphy et al. · The Journal of Experimental Medicine · 1994 · 510 citations · Full text
Júlio Aliberti, Charles N. Serhan, Alan Sher · The Journal of Experimental Medicine · 2002 · 202 citations · Full text
Ger van Zandbergen, Annalena Bollinger, Alexander Wenzel et al. · Proceedings of the National Academy of Sciences · 2006 · 192 citations · Full text
Rüdiger Vallon, Felix Freuler, Netsanet Desta-Tsedu et al. · The Journal of Immunology · 2001 · 165 citations · Full text